跳至主要内容
临床试验/CTRI/2024/09/074035
CTRI/2024/09/074035招募中不适用

To assess the long term outcomes of trabeculectomy augmented by injection technique of Mitomycin-C

Jolly Rohatgi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月20日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
1. IOP control after 5 years of surgery

研究概览

简要总结

Trabeculectomy, glaucoma surgery is known to fail over time due to fibrosis. Hence, to improve the outcomes of the surgery, antifibrotic drug like mitomycin C are used. One of the recent methods used is the injection method of mitomycin C. This study will assess the long term success of trabeculectomy surgery with the injection technique of mitomycin C after 5 years of surgery.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • All patients who underwent injection technique of mitomycin C injection of trabeculectomy from March 2017 to May 2018 at this institute.

排除标准

  • Rest all operated glaucoma surgery patients not satisfying the inclusion criteria.

结局指标

主要结局

1. IOP control after 5 years of surgery

时间窗: Single

2. Progression of Glaucoma

时间窗: Single

3. Any Long term complications of surgery

时间窗: Single

次要结局

  • Bleb morphology after 5 years of surgery using Indiana Bleb grading system(Single)

研究者

发起方
Jolly Rohatgi
申办方类型
Other []
责任方
Principal Investigator
主要研究者

JOLLY ROHATGI

UNIVERSITY COLLEGE OF MEDICAL SCIENCES AND GTB HOSPITAL

研究点 (1)

Loading locations...

相似试验